Disease landscape

Rheumatoid Arthritis clinical trials

Get alerts when Rheumatoid Arthritis trials change

470 active trials 237 recruiting 24 Phase 3 295 sponsors 47 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days showing 34 of 47 changes on 20 trials

2026-09-16
critical
Primary completion pushed: 2027-09-01 → 2028-08-01
Enrollment closed, study ongoing
Completion pushed: 2027-09-01 → 2028-08-01
NCT06299917 WORK-ON Vocational Rehabilitation for People With Inflammatory Arthritis · The Danish Center for Expertise in Rheumatology
2026-08-20
notable
Primary completion pushed: 2027-02-28 → 2027-07-28
Completion pushed: 2027-02-28 → 2027-07-28
NCT05277025 Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes · University of Florida
2026-08-22
critical
Primary endpoint(s) modified
NCT07764614 Tornier Perform™ Reversed Monopost Study · Stryker Trauma and Extremities
2026-09-15
notable
Enrollment closed, study ongoing
Primary completion pushed: 2026-08 → 2026-10
Completion pushed: 2026-11 → 2027-01
NCT07163221 At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study] · SecondWave Systems Inc.
2026-09-05
notable
Enrollment closed, study ongoing
NCT07048197 A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene… · Novartis Pharmaceuticals · Phase 1/2
2026-09-05
notable
Trial completed
Primary completion 2026-02-16, at least 200 days after the final estimate of 2025-07
NCT05638854 A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and… · Zenas BioPharma (USA), LLC · Phase 1
2026-08-25
notable
Recruitment opened
Trial sites reduced: 43 → 39 locations
NCT07412704 A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis · Bristol-Myers Squibb · Phase 1/2
2026-09-04
notable
Enrollment closed, study ongoing
Final enrollment: 65 participants (planned 75)
NCT06902519 Study of GS-0151 in Participants With Rheumatoid Arthritis · Gilead Sciences · Phase 1
2026-09-02
notable
Trial status changed: Not Yet Recruiting → Active, Not Recruiting
NCT07675226 Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions · Oscotec Inc. · Phase 1
2026-08-20
notable
Trial completed
Completion moved earlier: 2026-02 → 2025-10-15
NCT05533372 MAD Study of IA-14069 · ILAb Co., Ltd. · Phase 1
2026-09-12
notable
Enrollment closed, study ongoing
NCT06583980 INSELMA - a Randomised Controlled Trial · The Danish Center for Expertise in Rheumatology
2026-09-10
notable
Recruitment opened
Primary completion moved earlier: 2026-12-01 → 2026-10-01
Completion moved earlier: 2027-02-01 → 2026-11-01
NCT07456657 Effect of Lavender Aromatherapy Massage on Pain and Wrist Mobility in Rheumatoid Arthritis · University of Baghdad
2026-09-10
notable
Trial completed
Primary completion confirmed: August 2026 (last estimated May 2026)
NCT07264101 Validity And Reliability Of The Four Square Step Test In Individuals With Rheumatoid… · Inonu University
2026-08-18
notable
Recruitment opened
NCT07627893 Complementary Herbal Approach to Rheumatoid Management Study (CHARMS) · Singapore General Hospital · Phase 2/3
2026-08-28
notable
Trial completed
Primary completion moved earlier: 2026-04 → 2026-03-02
Completion moved earlier: 2026-04 → 2026-03-02
NCT06666452 COMFI - a COMbined Fatigue Intervention · The Danish Center for Expertise in Rheumatology
2026-08-27
notable
Enrolling by invitation only
NCT07188285 Mass Spectrometry-based Immune Profiling in Autoimmune Diseases · Peking University People's Hospital
2026-08-21
notable
Enrollment reopened
NCT07774507 Twenty-four Hour Movement Behaviors and Atherosclerotic Risk · São Paulo State University
2026-08-26
minor
Trial sites expanded: 56 → 63 locations
NCT07137598 A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to… · Hoffmann-La Roche · Phase 2
2026-08-22
minor
Trial sites expanded: 6 → 10 locations
NCT07473154 Controlling Hyperactive Immunity With Long-lived Lymphocytes · Quell Therapeutics Limited · Phase 1/2
2026-08-22
minor
Trial sites expanded: 6 → 9 locations
NCT07620392 An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants… · Hoffmann-La Roche · Phase 2

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-09-02 NCT07800871 FT839 in Autoimmune Diseases Fate Therapeutics new Phase 1/2
2026-08-21 NCT07779616 Study of PTC844 in Participants With Active Rheumatoid Arthritis PTC Therapeutics new Phase 2
2026-08-19 NCT07774507 Twenty-four Hour Movement Behaviors and Atherosclerotic Risk São Paulo State University new
2026-08-18 NCT07769619 Integrative AI-Based Multiomic and Neurophysiological Profiling of Chronic Pain in… 4th Military Clinical Hospital with Polyclinic, Poland new
2026-08-12 NCT07760662 Oxidative Stress and Cardiovascular Risk in Patients With Rheumatoid Arthritis University of La Laguna new
2026-07-31 NCT07740200 Validation of the Synovo Digital Disease Activity Score (DDAS) Against… Synovo Ltd. new
2026-07-30 NCT07737119 Impact of Optimised Protein Intake on Household Work Limitations and Disability in… Satguru Partap Singh Hospitals new
2026-07-28 NCT07729995 BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease Luminary Therapeutics new Phase 1
2026-07-24 NCT07726355 A Randomized Clinical Trial Evaluating the Efficacy of Clinical Pharmacist Assistance… Deraya University new Phase 2/3
2026-07-22 NCT07721142 Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory… Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine new Phase 4

Active trials by phase

Early Phase 1
8
Phase 1
47
Phase 1/2
13
Phase 2
45
Phase 2/3
4
Phase 3
20
Phase 4
33
Not charted: 300 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 470

NCT IDTitleSponsorStatusUpdated
Phase 4
NCT07802678 Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid… Sint Maartenskliniek Recruiting 2026-09-03
NCT06687551 JAK Inhibitor Dose TAPering Strategy Study University Hospital, Toulouse Recruiting 2026-08-07
NCT07721142 Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory… Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine Recruiting 2026-07-22
NCT07087912 Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in… University of Sao Paulo General Hospital Recruiting 2026-07-20
NCT07611747 Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in… Instituto de Investigación Marqués de Valdecilla Recruiting 2026-05-28
NCT07554820 Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate… Shaikh Zayed Hospital, Lahore Recruiting 2026-04-28
NCT07245732 Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares Sunnybrook Health Sciences Centre Recruiting 2026-04-13
NCT06528431 Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug… Centre Hospitalier Universitaire de Saint Etienne Recruiting 2025-12-26
NCT05955066 Effect of JAK Inhibitor on Erosion Healing in RA Chinese University of Hong Kong Recruiting 2025-12-04
NCT07160231 REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory… Sint Maartenskliniek Recruiting 2025-09-17
NCT04985435 Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With… R.Bos Recruiting 2025-08-08
NCT06906549 Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of… University Hospital, Strasbourg, France Recruiting 2025-07-23
NCT06003283 Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided… Universitaire Ziekenhuizen KU Leuven Recruiting 2025-05-31
NCT06913907 Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With… Keio University Recruiting 2025-04-06
NCT02714634 Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus… University Hospital, Strasbourg, France Recruiting 2025-03-12
NCT05540938 Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis China-Japan Friendship Hospital Recruiting 2025-01-20
NCT03976245 Advanced Therapeutics in Rheumatoid Arthritis (RA) London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Recruiting 2024-11-29
NCT06649136 MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active… Medical University of Vienna Recruiting 2024-10-18
NCT05626348 The Clinical Efficacy of Immunomodulators in RA Patients Qilu Hospital of Shandong University Recruiting 2022-11-29
NCT07643038 Treatment Strategy for Patients With RA-ILD Chinese SLE Treatment And Research Group Not Yet Recruiting 2026-09-03
NCT06440629 Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease… Diakonhjemmet Hospital Active, Not Recruiting 2026-07-01
NCT07636057 Comparison of Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to… Sheikh Zayed Federal Postgraduate Medical Institute Not Yet Recruiting 2026-06-09
NCT07582185 Tdose Binding and Tocilizumab Centre Hospitalier Universitaire de Nice Not Yet Recruiting 2026-05-12
NCT05879419 Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases University of Sao Paulo General Hospital Active, Not Recruiting 2026-05-04
NCT07452445 Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR… Tongji Hospital Not Yet Recruiting 2026-03-05

Top sponsors by active trials in this area

Get alerts when Rheumatoid Arthritis trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free